跳至主要内容
临床试验/NCT06237036
NCT06237036已完成不适用

Clinical Validation of a Computer-Aided Diagnosis (CAD) System Utilizing Artificial Intelligence Algorithms for Continuous and Remote Monitoring of Patient Condition Severity in an Objective and Stable Manner.

AI Labs Group S.L1 个研究点 分布在 1 个国家目标入组 160 人开始时间: 2022年3月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
160
试验地点
1
主要终点
Malignancy

研究概览

简要总结

The goal of this observational prospective and analytical study is to evaluate the effectiveness of the device developed by Legit.Health in remotely monitoring the severity of chronic dermatologic pathologies. Secondly, to assess patient satisfaction with the device for remote monitoring. All this in patients diagnosed with any of the specified chronic dermatological conditions that meet the inclusion criteria. These patients are attended at the Dermatology Department of the Hospital Universitario de Torrejón.

The study proceeded as follows:

Patient Selection and Recruitment Visit The recruitment period spanned six months, during which investigators identified eligible patients. The Principal Investigator (PI) or designated collaborating investigators explained the study details to potential participants using the Patient Information Sheet. Patients had the opportunity to seek clarification on any aspects of the study. If a patient chose to participate, they provided informed consent and received a study code. Data collection commenced post-consent. During this initial visit, patients used the device under the supervision of the research team to complete questionnaires and capture photographs associated with their pathology.

Subsequently, the patient autonomously and remotely continued the data collection process at home, as detailed in the following section.

The device was provided at no cost to patients and the research team for the study's duration.

Procedures Performed by the Patient at Home Completion of Questionnaires Patients independently reported on their condition from home, following instructions provided by the research team and the "Patient Information Guide" integrated into Legit.Health, in conjunction with photograph submissions.

Every two months, patients completed the "Patient Satisfaction Questionnaire" addressing general user experience aspects. Additionally, they completed the System Usability Scale (SUS) Questionnaire at the same frequency

Image capture

Patients simultaneously took photographs of the affected areas while completing questionnaires through the app. These photographs were captured using the patient's smartphone from their homes in an autonomous manner. The frequency of photograph submission was determined by the consulting specialist. No specialized camera equipment was required; patients used the camera available on their smartphones. Patients then transmitted these photographs to the research team through a web app Both patients and members of the medical team possessed access credentials.

The manufacturer did not have access to patient accounts or information. Data transfer and photograph storage adhered to the European Regulation 2016/679 of 27 April on the protection of natural persons with regard to the processing of personal data and the free movement of such data, as well as the Organic Law 3/2018 of 5 December on the Protection of Personal Data and guarantee of digital rights.

详细描述

Introduction This clinical investigation marks a pivotal stage in the development of the Legit.Health software medical device, designed to enhance dermatological diagnostics using advanced machine vision and deep learning. The study focuses on evaluating the device's effectiveness in remotely monitoring chronic dermatologic conditions and assessing patient satisfaction. With a diverse cohort of 160 patients, rigorous ethical standards, and adherence to regulatory guidelines, this research holds significant potential in revolutionizing dermatological diagnostics.

Objectives Primary objective The primary aim of this study is to ascertain the validity of the device, leveraging artificial intelligence and developed by AI Labs Group S.L., in objectively and reliably tracking the progression of chronic dermatological conditions. This validation is deemed successful if the tool achieves a score of 8 or higher in the Clinical Utility Questionnaire (CUS).

Secondary objectives

In addition to the primary objective, secondary objectives encompass:

Confirming that the utilization of the device elicits a high level of patient satisfaction, particularly in its remote application.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have provided their informed consent for participation in the study.
  • Patients who demonstrate proficiency in both written and spoken Spanish or English.
  • Patients who possess a smartphone, defined as a phone equipped with internet access and an integrated camera, regardless of make, model, or technical specifications.

排除标准

  • Patients who, as determined by the investigator, did not adhere to the study procedures.
  • Patients who were already utilizing the tool under investigation prior to the commencement of the study

结局指标

主要结局

Malignancy

时间窗: through study completion, an average of 1 year

Malignancy of the lesion detected by the tool

Utility

时间窗: At the end of the study, up to 1 month

Utility of the application referred by the clinicians

次要结局

  • Sex and age(through study completion, an average of 1 year)
  • Diagnosis(through study completion, an average of 1 year)
  • Quality of life noticed by patients(through study completion, an average of 1 year)
  • Satisfaction of patients(At the time of recruitment of the last patient in the study, up to 4 weeks)

研究者

发起方
AI Labs Group S.L
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验